ctrl K

Roivant Sciences Ltd. (ROIV)

NASDAQ: ROIV · Real-Time Price · USD

11.59

-0.03 (-0.26%)

At close: May 01, 2025, 3:59 PM

Roivant Sciences Ratios and Metrics

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
PE Ratio	1.88	-5.21	-3.91	-8.28	1.87
PEG Ratio	-0.00	-0.41	-0.58	0.07	n/a
PS Ratio	65.46	85.84	59.84	281.46	33.09
PB Ratio	1.37	4.54	2.00	3.73	1.10
P/FCF Ratio	-10.66	-6.14	-4.76	-12	-2.92
P/OCF Ratio	-10.68	-6.24	-4.88	-12.13	-2.94
OCF/S Ratio	-6.13	-13.76	-12.26	-23.2	-11.25
Debt / Equity Ratio	0.08	0.42	0.17	0.14	0.09
Quick Ratio	25.10	6.59	11.64	9.99	24.09
Current Ratio	25.24	6.60	11.64	9.99	24.09
Asset Turnover	0.02	0.03	0.02	0.01	0.03
Interest Coverage	121.97	-42.02	-191.97	-381.24	-69.3
Return on Equity	0.73	-0.87	-0.51	-0.45	0.59
Return on Assets	0.60	-0.42	-0.33	-0.3	0.48
Return on Invested Capital	0.60	-0.54	-0.56	-0.45	-0.23
Dividend Yield	0.00	n/a	n/a	n/a	n/a
Payout Ratio	0.00	n/a	n/a	n/a	n/a
Gross Profit Margin	0.78	0.79	0.84	0.91	0.98
Net Profit Margin	34.85	-16.47	-15.29	-34.01	17.74
Pretax Profit Margin	34.08	-19.99	-16.71	-37.76	-8.29
Operating Profit Margin	33.99	-19.18	-24.45	-45.01	-7.87
FCF Margin	n/a	n/a	n/a	n/a	n/a
EBITDA Margin	34.54	-19.22	-16.58	-37.64	-8.17